Langtids-covid
Fluvoxamin lindrer alvorlig utmattelse hos pasienter med langvarig covid
Rapportert av AI Bilde generert av AI
En studie viser at antidepressivaet fluvoxamin reduserer alvorlig utmattelse hos pasienter med langvarig covid. I en randomisert studie med 399 voksne ble middelet sammenlignet med metformin og placebo. Overlege Judith Bruchfeld beskriver funnene som interessante.
A major randomized trial led by Mass General Brigham found that a four-week course of high-dose vitamin D3 started soon after a positive COVID-19 test did not reduce acute illness severity, healthcare visits or deaths, and did not curb household spread. But in an analysis limited to participants who consistently took the assigned pills, researchers observed a small, borderline statistically significant difference in lingering symptoms reported eight weeks after infection, a finding they say warrants further study.
Rapportert av AI Faktasjekket
New research syntheses suggest long COVID—typically defined as symptoms lasting at least two months after SARS‑CoV‑2 infection with no alternative explanation—may be driven by overlapping processes including viral persistence, chronic inflammation and tiny blood clots. Scientists say there are still no approved, evidence-based treatments, though rehabilitation strategies and several experimental approaches, including metformin given early in infection, are under study.